Drug Profile
Research programme: migraine and pain therapeutics - NeurAxon
Alternative Names: nNOS inhibitors - NeurAxon; nNOS/iNOS - NeurAxon; nNOS/NET - NeurAxon; nNOS/Opiate - NeurAxonLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator NeurAxon
- Class Small molecules
- Mechanism of Action Adrenergic receptor modulators; Nitric oxide synthase type I inhibitors; Nitric oxide synthase type II inhibitors; Opioid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Inflammatory pain; Migraine; Neuropathic pain; Pain
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Inflammatory-pain in Canada (PO)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Migraine(Prevention) in Canada (PO)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Neuropathic-pain in Canada (PO)